The BIO International Convention was held in Boston from June 5 to 8, 2023. Approximately 400 French companies were present, making France the second-largest foreign delegation from outside North America. … Read more
Discover our newest members joining the French Healthcare Association network in September : The ACIA specializes in providing equipment and services for many international projects. It offers a full support for its … Read more
Toutenkamion, the European leader for mobile units, has been visited by several Egyptian buyers in its premises located in the Loiret. The delegation had already met the company during the second edition of the French Healthcare Innovation and Business Forum, which took place in the Maison de la Chimie on the 18thand 19th of September.
The diabetes treatment specialist has used AI to assess the impact of the menstrual cycle and hormonal variations on women’s insulin requirements. Type 1 diabetes affects 250,000 people in France … Read more
At the end of April, Cousin Surgery, the French specialist in implantable textiles, completed the purchase of the German company behind the development of 4DRYFIELD, a hemostatic product that prevents … Read more
Two researchers from the Metabolic and Cardiovascular Research Institute/Inserm in Toulouse are currently developing a biosensor that can be implanted in a tooth to measure blood glucose levels. What if, … Read more
At the end of April, the US authority lifted the clinical hold on the “pooling” technology developed by Maat Pharma in patients with Acute Graft-versus-Host disease. “This is the first time … Read more
The team at the leading center for rare vascular diseases of the Georges-Pompidou European Hospital, Inserm and Paris Cité University published its work in the journal eBioMedicine in March 2023. … Read more
This three-year EU4Health project was launched in April 2023 as part of the Europe’s Beating Cancer Plan. It is specifically aimed at women and disadvantaged, vulnerable and geographically isolated communities. … Read more
International medical imaging specialist Guerbet has become the major shareholder in Intrasense, which continues to operate as an autonomous entity. Intrasense will incorporate the algorithms developed by Guerbet and other … Read more
Thanks to its strong expertise in Gene Reporter, Promega has been able to develop new bioassays for characterizing T cell activation (“T Cell Activation Bioassay for Transgenic TCRs”) in support … Read more
Bora Care, Biosency’s medical device which aims to improve the care pathway for patients with respiratory insufficiency, will be marketed in eleven new countries via a strategic partnership with Australian … Read more